» Articles » PMID: 38993878

Acellular Dermal Matrix in Reconstructive Surgery: Applications, Benefits, and Cost

Overview
Specialty General Surgery
Date 2024 Jul 12
PMID 38993878
Authors
Affiliations
Soon will be listed here.
Abstract

Modern tissue engineering has made substantial advancements that have revolutionized plastic surgery. Acellular dermal matrix (ADM) is an example that has gained considerable attention recently. ADM can be made from humans, bovines, or porcine tissues. ADM acts as a scaffold that incorporates into the recipient tissue. It is gradually infiltrated by fibroblasts and vascularized. Fortunately, many techniques have been used to remove cellular and antigenic components from ADM to minimize immune system rejection. ADM is made of collagen, fibronectin, elastin, laminin, glycosaminoglycans, and hyaluronic acid. It is used in critical wounds (e.g., diabetic wounds) to protect soft tissue and accelerate wound healing. It is also used in implant-based breast reconstruction surgery to improve aesthetic outcomes and reduce capsule contracture risk. ADM has also gained attention in abdominal and chest wall defects. Some studies have shown that ADM is associated with less erosion and infection in abdominal hernias than synthetic meshes. However, its higher cost prevents it from being commonly used in hernia repair. Also, using ADM in tendon repair (e.g., Achilles tendon) has been associated with increased stability and reduced rejection rate. Despite its advantages, ADM might result in complications such as hematoma, seroma, necrosis, and infection. Moreover, ADM is expensive, making it an unsuitable option for many patients. Finally, the literature on ADM is insufficient, and more research on the results of ADM usage in surgeries is needed. This article aims to review the literature regarding the application, Benefits, and costs of ADM in reconstructive surgery.

Citing Articles

The safety and anti-adhesive effect of acellular dermal matrix application after thyroid surgery: a multicenter randomized controlled trial.

Kim K, Chai Y, Han M, Kang S, Yun J Ann Surg Treat Res. 2025; 108(2):71-78.

PMID: 39944927 PMC: 11813551. DOI: 10.4174/astr.2025.108.2.71.


Advancements in bioengineered and autologous skin grafting techniques for skin reconstruction: a comprehensive review.

Dean J, Hoch C, Wollenberg B, Navidzadeh J, Maheta B, Mandava A Front Bioeng Biotechnol. 2025; 12():1461328.

PMID: 39840132 PMC: 11747595. DOI: 10.3389/fbioe.2024.1461328.


Sternal Wound Reconstruction Following Deep Sternal Wound Infection: Past, Present and Future: A Literature Review.

Khashkhusha A, Butt S, Abdelghaffar M, Wang W, Rajananthanan A, Roy S J Cardiovasc Dev Dis. 2024; 11(11).

PMID: 39590204 PMC: 11595137. DOI: 10.3390/jcdd11110361.


Current advances in the development of microRNA-integrated tissue engineering strategies: a cornerstone of regenerative medicine.

Castanon-Cortes L, Bravo-Vazquez L, Santoyo-Valencia G, Medina-Feria S, Sahare P, Duttaroy A Front Bioeng Biotechnol. 2024; 12:1484151.

PMID: 39479296 PMC: 11521876. DOI: 10.3389/fbioe.2024.1484151.


The current techniques in dorsal augmentation rhinoplasty: a comprehensive review.

Nikparto N, Yari A, Mehraban S, Bigdelou M, Asadi A, Darehdor A Maxillofac Plast Reconstr Surg. 2024; 46(1):16.

PMID: 38678507 PMC: 11056355. DOI: 10.1186/s40902-024-00418-9.


References
1.
Cigerim L . Treatment of Exposed Bone With Acellular Dermal Matrix in a Smoker Patient After Dental Implant Surgery: A Case Report. J Oral Implantol. 2019; 46(3):245-249. DOI: 10.1563/aaid-joi-D-19-00221. View

2.
Guo X, Mu D, Gao F . Efficacy and safety of acellular dermal matrix in diabetic foot ulcer treatment: A systematic review and meta-analysis. Int J Surg. 2017; 40:1-7. DOI: 10.1016/j.ijsu.2017.02.008. View

3.
Kavros S, Dutra T, Gonzalez-Cruz R, Liden B, Marcus B, McGuire J . The use of PriMatrix, a fetal bovine acellular dermal matrix, in healing chronic diabetic foot ulcers: a prospective multicenter study. Adv Skin Wound Care. 2014; 27(8):356-62. DOI: 10.1097/01.ASW.0000451891.87020.69. View

4.
Heine N, Hoesl V, Seitz S, Prantl L, Brebant V . Implant-based immediate reconstruction in prophylactic mastectomy: is the caudal dermis flap a reliable alternative to synthetic mesh or acellular dermal matrix?. Arch Gynecol Obstet. 2021; 305(4):937-943. PMC: 8967752. DOI: 10.1007/s00404-021-06244-y. View

5.
Luan A, Patel A, Martin S, Nazerali R . Single-Unit technique for the use of acellular dermal matrix in immediate expander-based breast reconstruction. J Plast Reconstr Aesthet Surg. 2020; 74(5):981-986. DOI: 10.1016/j.bjps.2020.10.048. View